Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
- PMID: 8795671
- PMCID: PMC472555
- DOI: 10.1136/thx.51.8.819
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
Abstract
Background: An increase in resting energy expenditure (REE) commonly occurs in patients with chronic obstructive pulmonary disease (COPD), the cause of which is as yet unknown. The objective of this study was to assess the relationship between REE, acute phase proteins, and inflammatory mediators in patients with COPD.
Methods: Thirty patients were studied and 26 healthy age-matched subjects served as controls. REE was measured by indirect calorimetry and adjusted for fat-free mass (FFM) by bioelectrical impedance analysis. Tumour necrosis factor alpha (TNF-alpha), soluble tumour necrosis receptor (sTNF-R)55 and sTNF-R75, interleukin (IL)-6, IL-8, and lipopolysaccharide binding protein (LBP) were measured by ELISA.
Results: Fourteen patients had a normal REE and in 16 it was raised. The mean body mass index and fat mass were significantly lower in the latter but pulmonary function data were similar in the two groups. In the 30 patients with COPD the mean (SD) sTNF-R75 was 1.7 (1.0) ng/ml compared with 1.1 (0.4) ng/ml in the controls; C-reactive protein (CRP) was detectable (> 5 micrograms/ml) in eight patients compared with none of the control subjects, and LBP was 13.2 (7.7) micrograms/ml compared with 8.6 (3.1) micrograms/ml in the controls. The patients with a raised REE had increased mean levels of CRP compared with the patients with a normal REE (median 5.5 micrograms/ml (range 5-193) and < 5 micrograms/ml, respectively); the same was true for LBP (median 12.4 micrograms/ml (range 8.1-39.1) and 9.5 micrograms/ml (range 5.0-16.6), respectively), but sTNF-R55 and R75 and IL-8 were similar in the two groups. Of the 16 patients with a raised REE, the CRP level was increased in eight and normal in eight. In those with an increased level of CRP the FFM was decreased and LBP, IL-8, and sTNF-R55 and R75 were increased compared with those with normal CRP levels.
Conclusions: A subset of patients with COPD with an increased REE and decreased FFM have increased levels of acute phase reactant proteins and inflammatory cytokines in their serum; these phenomena may be causally related.
Similar articles
-
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.Thorax. 2001 Sep;56(9):721-6. doi: 10.1136/thorax.56.9.721. Thorax. 2001. PMID: 11514694 Free PMC article.
-
Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.J Clin Oncol. 1995 Oct;13(10):2600-5. doi: 10.1200/JCO.1995.13.10.2600. J Clin Oncol. 1995. PMID: 7595713
-
The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1179-84. doi: 10.1164/ajrccm.161.4.9903022. Am J Respir Crit Care Med. 2000. PMID: 10764309
-
Systemic inflammation in COPD: is genetic susceptibility a key factor?COPD. 2006 Mar;3(1):51-61. doi: 10.1080/15412550500493436. COPD. 2006. PMID: 17175665 Review.
-
TNF-alpha and hypermetabolism in chronic obstructive pulmonary disease.Clin Nutr. 1999 Oct;18(5):255-7. doi: 10.1016/s0261-5614(98)80021-6. Clin Nutr. 1999. PMID: 10601531 Review. No abstract available.
Cited by
-
Systemic inflammation, depression and obstructive pulmonary function: a population-based study.Respir Res. 2013 May 15;14(1):53. doi: 10.1186/1465-9921-14-53. Respir Res. 2013. PMID: 23676005 Free PMC article.
-
Plasma inflammatory biomarkers response to aerobic versus resisted exercise training for chronic obstructive pulmonary disease patients.Afr Health Sci. 2016 Jun;16(2):507-15. doi: 10.4314/ahs.v16i2.19. Afr Health Sci. 2016. PMID: 27605966 Free PMC article. Clinical Trial.
-
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.Thorax. 2001 Sep;56(9):721-6. doi: 10.1136/thorax.56.9.721. Thorax. 2001. PMID: 11514694 Free PMC article.
-
Altered tissue distribution in adults with cystic fibrosis.Thorax. 2003 Oct;58(10):885-9. doi: 10.1136/thorax.58.10.885. Thorax. 2003. PMID: 14514945 Free PMC article.
-
Targeted treatment in COPD: a multi-system approach for a multi-system disease.Int J Chron Obstruct Pulmon Dis. 2009;4:321-35. doi: 10.2147/copd.s2999. Epub 2009 Sep 1. Int J Chron Obstruct Pulmon Dis. 2009. PMID: 19750192 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous